Umzimveliso oPhakamileyo oPhakamileyo weCabozantinib Malate CAS 1140909-48-3 yeAnti-Tumor

Inkcazelo emfutshane:

Umhlaza womlomo wesibeleko, okwaziwa ngokuba ngumhlaza womlomo wesibeleko, lelona thumba lixhaphakileyo kwi-gynecological tract kumzila wokuzala wabasetyhini.I-HPV ngowona mngcipheko ubalulekileyo wesi sifo.Umhlaza womlomo wesibeleko unokuthintelwa ngokuhlolwa rhoqo kunye nokugonywa.Umhlaza womlomo wesibeleko kwangethuba unyangekile kakhulu kwaye uqikelelo lulungile.


Iinkcukacha zeMveliso

Iithegi zeMveliso

Okugqwesileyo kuza 1st;inkonzo iphambili;ishishini elincinci yintsebenziswano” yintanda-bulumko yombutho wethu ejongwa rhoqo kwaye ilandelwa yinkampani yethu yoMgangatho oPhakamileyo weCabozantinib Malate CAS 1140909-48-3 ye-Anti-Tumor, Ngenxa yokusebenza nzima kwethu, besihlala sijikeleza. phambili kwiteknoloji ecocekileyo yokuthengisa izinto ezintsha.Siye saba liqabane eco-friendly onokuthi uthembele.Sifumane namhlanje ngedatha eyongezelelweyo!
Okugqwesileyo kuza 1st;inkonzo iphambili;ishishini elincinci yintsebenziswano” yintanda-bulumko yombutho wethu ejongwa rhoqo kwaye ilandelwa yinkampani yethuI-China Cabozantinib Malate CAS 1140909-48-3 kunye neCabozantinib Malate CAS 1140909-48-3 Umnikezeli, ngoku sineminyaka eyi-8 yamava emveliso kunye neminyaka emi-5 yamava ekurhwebeni kunye nabathengi kwihlabathi liphela.abathengi bethu basasazwa ikakhulu kuMntla Melika, eAfrika naseMpuma Yurophu.sinokubonelela ngeemveliso ezikumgangatho ophezulu ngexabiso elikhuphisana kakhulu.
I-Epidemiology
I-WHO yakhupha ngo-2018 ukuba iziganeko zehlabathi zomhlaza womlomo wesibeleko zimalunga ne-13 kubantu abayi-100000 e-Wei minyaka le, kwaye izinga lokufa limalunga ne-7 kubantu abayi-100000 ababulawa ngumhlaza womlomo wesibeleko.Ngo-2018, bekukho malunga ne-569000 yamatyala amatsha omhlaza womlomo wesibeleko kunye nokufa kwe-311000, apho i-84% yenzeke kumazwe amashishini athengisayo.
Ukugula nokufa komhlaza womlomo wesibeleko kwihlabathi jikelele kwehle kakhulu kule minyaka ingama-40 idlulileyo, nto leyo enxulumene nokomelezwa kwemfundo yezempilo, ugonyo lwe-HPV kunye nokuhlolwa komhlaza womlomo wesibeleko.

Esi sifo sixhaphake kakhulu kubasetyhini abaneminyaka ephakathi (35-55y).Iipesenti ezingama-20 zamatyala zenzeka ngaphezu kweminyaka engama-65 kwaye zinqabile kulutsha.

Iindlela zokuxilonga umhlaza womlomo wesibeleko:
1. Uviwo lwe-Cytological of curettage yomlomo wesibeleko.
Le ndlela inokubona izilonda ze-cervical precancerous kunye nomhlaza womlomo wesibeleko kwangoko, kuba kukho ubuxoki obungalunganga be-5% mi 10%, ngoko ke izigulane kufuneka zihlolwe rhoqo.
2. Uvavanyo lwe-iodine.
I-epithelium yomlomo wesibeleko eqhelekileyo kunye ne-vaginal squamous epithelium zizityebi kwi-glycogen kwaye inokuthi ifakwe i-brown ngesisombululo se-iodine, ngelixa ukhukuliseko lomlomo wesibeleko kunye ne-epithelium engaqhelekanga ye-squamous (kubandakanywa ne-atypical hyperplasia, i-carcinoma in situ kunye ne-invasive carcinoma) ayikho kwaye ayiyi kuba nebala.
3. I-Biopsy yomlomo wesibeleko kunye nomsele womlomo wesibeleko.
Ukuba i-cytology yomlomo wesibeleko ikwibakala Ⅲ ~ Ⅳ, kodwa i-biopsy yomlomo wesibeleko ayinayo, izicubu ezininzi kufuneka zithathelwe uviwo lwe-pathological.
4. ColposcopyEgqwesileyo iza 1st;inkonzo iphambili;ishishini elincinci yintsebenziswano” yintanda-bulumko yombutho wethu ejongwa rhoqo kwaye ilandelwa yinkampani yethu yoMgangatho oPhakamileyo weCabozantinib Malate CAS 1140909-48-3 ye-Anti-Tumor, Ngenxa yokusebenza nzima kwethu, besihlala sijikeleza. phambili kwiteknoloji ecocekileyo yokuthengisa izinto ezintsha.Siye saba liqabane eco-friendly onokuthi uthembele.Sifumane namhlanje ngedatha eyongezelelweyo!
Eyona Factory itshiphuI-China Cabozantinib Malate CAS 1140909-48-3 kunye neCabozantinib Malate CAS 1140909-48-3 Umnikezeli, ngoku sineminyaka eyi-8 yamava emveliso kunye neminyaka emi-5 yamava ekurhwebeni kunye nabathengi kwihlabathi liphela.abathengi bethu basasazwa ikakhulu kuMntla Melika, eAfrika naseMpuma Yurophu.sinokubonelela ngeemveliso ezikumgangatho ophezulu ngexabiso elikhuphisana kakhulu.


  • Ngaphambili:
  • Okulandelayo:

  • Iimveliso ezinxulumeneyo